Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2007 1
2013 2
2014 3
2016 1
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance.
Ito S, Saito A, Sakurai A, Watanabe K, Karakawa S, Miyamura T, Yokosuka T, Ueki H, Goto H, Yagasaki H, Kinoshita M, Ozeki M, Yokoyama N, Teranishi H. Ito S, et al. Among authors: ueki h. Bone Marrow Transplant. 2024 Mar;59(3):315-324. doi: 10.1038/s41409-023-02161-7. Epub 2023 Dec 15. Bone Marrow Transplant. 2024. PMID: 38102212 Free PMC article.
The impact of vitamin D on the onset and progress of Kawasaki disease.
Okazaki N, Ikeda H, Honda T, Tsuno K, Inoue F, Takahashi S, Sakurai A, Ueki H, Noguchi Y, Hamada H, Igarashi S. Okazaki N, et al. Among authors: ueki h. Pediatr Int. 2022 Jan;64(1):e15191. doi: 10.1111/ped.15191. Pediatr Int. 2022. PMID: 35831250
Osteosarcoma after bone marrow transplantation.
Ueki H, Maeda N, Sekimizu M, Tsukushi S, Nishida Y, Horibe K. Ueki H, et al. J Pediatr Hematol Oncol. 2013 Mar;35(2):134-8. doi: 10.1097/MPH.0b013e3182677f19. J Pediatr Hematol Oncol. 2013. PMID: 22995925
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Igarashi S, Sato A, Hori T, Saito AM, Watanabe T, Deguchi T, Manabe A, Horibe K, Toyoda H. Ueki H, et al. Int J Hematol. 2024 Apr;119(4):450-458. doi: 10.1007/s12185-024-03710-6. Epub 2024 Jan 25. Int J Hematol. 2024. PMID: 38267673
12 results